GoodRx Holdings (GDRX) Operating Leases (2019 - 2026)

GoodRx Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $49.0 million for Q1 2026.

• In Q1 2026, Operating Leases rose 9.28% year-over-year to $49.0 million; the TTM figure through Mar 2026 stood at $49.0 million (up 9.28% YoY), while the FY2025 annual figure was $49.8 million, up 8.14% from the prior year.
• Operating Leases came in at $49.0 million for Q1 2026 at GoodRx Holdings, down from $49.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $56.3 million in Q1 2023 to a low of $32.5 million in Q1 2022.
• A 5-year average of $47.4 million and a median of $49.3 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases soared 73.1% in 2023 and dropped 12.75% in 2025, its largest moves.
• GoodRx Holdings' Operating Leases stood at $54.1 million in 2022, then dropped by 10.58% to $48.4 million in 2023, then dropped by 4.88% to $46.0 million in 2024, then advanced by 8.14% to $49.8 million in 2025, then declined by 1.68% to $49.0 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $49.0 million, $49.8 million, and $51.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison